{"disease":{"id":"antibody-deficiency","name":"antibody deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05612607","title":"Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT01581593","title":"Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Kedrion S.p.A.","has_results":true},{"nct_id":"NCT03211689","title":"The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Stockton University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}